Skip to main content

Detail

Florian Fitzal
Prof. Dr. Florian Fitzal, F.E.B.S, MBAChief Breast Surgery

Department of Surgery (Division of General Surgery)
Position: Professor

ORCID: 0000-0003-2617-3965
T +43 1 40400 562120
florian.fitzal@meduniwien.ac.at

Further Information

Keywords

Breast Neoplasms; General Surgery; Hernia; Reconstructive Surgical Procedures

Research group(s)

Research interests

  • Oncoplastic Surgery
  • Lymph node Surgery in breast cancer
  • breast cancer surgery
  • moedern breast cancer therapies

Techniques, methods & infrastructure

University Medical Hospital with largest Breast Health Center in Austria, caselode 600/year

Grants

  • Growth factors in breast cancer surgery (2009)
    Source of Funding: Austrian Society of Senology, ABCSG28
    Principal Investigator
  • POSYTIVE - Primary operation in synchroneous metastasized invasive breast cancer (2009)
    Source of Funding: Medical Scientific Fund of the Mayor of the City of Vienna,
    Principal Investigator
  • Einfluß intestinaler Proteaseninhibition auf die Mortalität bei Peritonitis-induziertem septischen Schock in der Ratte (2003)
    Source of Funding: OeNB (Oesterreichische Nationalbank), Anniversary Fund
    Principal Investigator
  • Microcirculation in shock (2000)
    Source of Funding: OeAW (Austrian Academy of Sciences), MAX KADE
    Principal Investigator

Selected publications

  1. Gnant, M. et al., 2015. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet, 386(9992), pp.433-443. Available at: http://dx.doi.org/10.1016/S0140-6736(15)60995-3.
  2. Fitzal, F. et al., 2015. The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial. British Journal of Cancer, 112(8), pp.1405-1410. Available at: http://dx.doi.org/10.1038/bjc.2015.98.
  3. Gnant, M. et al., 2009. Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer. New England Journal of Medicine, 360(7), pp.679-691. Available at: http://dx.doi.org/10.1056/NEJMoa0806285.
  4. Anon, 2013. German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer. European Journal of Cancer, 49(10), pp.2277-2283. Available at: http://dx.doi.org/10.1016/j.ejca.2013.01.034.
  5. Fitzal, F. et al., 2008. Breast-Conserving Therapy for Centrally Located Breast Cancer. Annals of Surgery, 247(3), pp.470-476. Available at: http://dx.doi.org/10.1097/SLA.0b013e31815b6991.